For the price of a weekend trip, your genetic blueprint could reveal health risks decades before they emerge.
DNA testing was something reserved for research labs, wealthy early adopters and patients with rare diseases. But what happens when reading your genome becomes cheaper than a weekend getaway?
That’s the question driving the latest episode of Longevity.Technology UNLOCKED, hosted by Phil Newman and Dr Nina Patrick, where Human Longevity Inc (HLI) CEO and Executive Chairman Dr Wei-Wu He argues that genomics is approaching the same tipping point as smartphones or electric vehicles: once prohibitively expensive, now steadily becoming accessible to the public.
“We human race [are] embracing a brand new form of medicine,” He says. “Which is genomic-powered, multi-omics data, an AI-powered system, which [the] human race has never experienced before.”
An ambitious claim, sure, but beneath the enthusiasm lies a broader shift that is reshaping longevity medicine – not treating disease once it appears, but identifying biological risk years, even decades, before symptoms emerge.
A blueprint written at birth
The central premise is that your DNA is the one medical record you receive the day you’re born. Unlike cholesterol, blood pressure or blood sugar – which fluctuate throughout life – your genome remains constant. Sequence it once, and in theory, it becomes a lifelong reference point.
As He explains, “we all… came to this world with 6 billion code in a single cell, but [the] human race… has wandered on Earth for 300,000 years. We never knew our code.”
The “code,” he argues, is proving more influential than medicine once believed. Recent research increasingly suggests genetics plays a substantial role in lifetime disease risk. Rather than replacing lifestyle, genomic information helps identify who may need earlier screening, closer monitoring or preventive interventions long before disease develops.
The challenge has been affordability, not scientific possibility. A decade ago, whole-genome sequencing cost roughly $10,000. HLI has now launched a consumer offering priced at $599.
“If you live a hundred years, it’s five, six dollars a year. I don’t think anybody can complain they cannot dish out the five, six dollars a year to access your genome knowledge,” He said.
When AI becomes the second set of eyes
DNA alone, however, is only one piece of the puzzle. HLI combines genomic data with imaging, blood biomarkers, microbiome analysis and other biological measurements – a growing field known as multi-omics. The goal is to build AI systems capable of connecting thousands of subtle signals that even experienced clinicians might miss.
“Our human body is by far the most complex machine on Earth,” He says. “No human being can remember 50,000 human diseases… But I think AI can.”
Rather than replacing physicians, He envisions AI functioning much like an exceptionally attentive co-pilot, one that never gets tired, never forgets a paper published years ago and can continuously compare new information against enormous datasets.
He points to AI-assisted mammography as one example, where algorithms are beginning to detect patterns that rival (or, in some cases, outperform) experienced radiologists.
The bigger vision extends beyond individual scans. HLI recently partnered with Insilico Medicine to develop foundation AI models trained on deep biological data, with the hope of improving disease prediction and eventually accelerating drug discovery.
Prevention becomes personal
Perhaps the strongest argument for precision medicine comes from patients whose outcomes changed because hidden risks were uncovered early. He describes one man whose father and grandfather both died of heart attacks in their fifties. Genome sequencing revealed a mutation in the PCSK9 gene associated with inherited high cholesterol. Armed with that information, physicians recommended targeted therapy.
“I think this particular client probably will never follow the fate of his father and his grandfather,” He said.
Another story illustrates how combining AI with multiple diagnostic tools can reveal what standard testing overlooks. An older woman received a positive cancer signal through blood-based screening, but her colonoscopy appeared normal. Rather than dismissing the result, clinicians used AI-supported reasoning to investigate further. The cancer wasn’t in her colon at all; it was in her appendix.
After surgery, “she’s cured,” He described.
Stories like these don’t suggest technology is infallible. Instead, they highlight how combining different sources of biological information can reduce blind spots that exist when tests are interpreted in isolation.
Democratizing longevity or widening the gap?
Despite the optimism, precision medicine still faces significant challenges. Most healthcare systems remain designed to react to disease rather than anticipate it. Whole-genome sequencing raises difficult questions around privacy, interpretation and equitable access. Even if sequencing becomes inexpensive, follow-up imaging, specialist consultations and preventive treatments remain unevenly distributed across the world.
He acknowledges that education may prove as important as the technology itself. Reflecting on the continued global deaths from cervical cancer despite the availability of HPV vaccines, he argues that scientific breakthroughs alone are never enough.
“The most difficult task is to communicate people,” He explains. “Actually… for five dollars a year genome, you actually can avoid a lot of diseases.”
Whether that prediction proves correct remains to be seen, but the conversation points that medicine is gradually shifting from asking “What disease do you have today?” toward a more provocative question: “What does your biology suggest could happen tomorrow?”
If that future arrives, your genome may become less like a laboratory report and more like a lifelong map, one that doesn’t determine your destination but helps you navigate the road ahead.
New episodes of Longevity.Technology UNLOCKED drop every Monday, featuring researchers, founders and innovators shaping the future of healthy longevity. A weekly news roundup follows each Friday. Tune in on Apple Podcasts, Spotify or YouTube.
